119th Congress
S. 4355
Drug Deal Disclosure Act
- Introduced
- In committee
- Passed Senate
- Passed House
- To President
- Became law
- Sponsor
- Ron Wyden(D-OR)
- Introduced
- Apr 21, 2026
- Policy area
- Health
- Committees
- Senate Committee on Health, Education, Labor, and Pensions
- Official text
- Introduced in Senate · Congress.gov page
Cosponsors (18)
Original cosponsors (17)
- Ben Ray Luján (D-NM)
- Bernard Sanders (I-VT)
- Catherine Cortez Masto (D-NV)
- Elizabeth Warren (D-MA)
- Jeff Merkley (D-OR)
- Margaret Wood Hassan (D-NH)
- Maria Cantwell (D-WA)
- Mark Kelly (D-AZ)
- Mark R. Warner (D-VA)
- Mazie K. Hirono (D-HI)
- Michael F. Bennet (D-CO)
- Peter Welch (D-VT)
- Raphael G. Warnock (D-GA)
- Ruben Gallego (D-AZ)
- Sheldon Whitehouse (D-RI)
- Tammy Baldwin (D-WI)
- Tina Smith (D-MN)
Added later (1)
- Chris Van Hollen (D-MD) · Apr 27, 2026
Summary
No Congressional Research Service summary yet. CRS usually publishes one a few weeks after a bill is introduced.
Official title: A bill to require the Department of Health and Human Services to release documents, communications, and other information relating to most favored nation pricing agreements and other private or confidential drug pricing deals struck with manufacturers, and for other purposes.
Latest action(Apr 21, 2026): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Roll-call votes
No recorded votes on this bill.
Actions
- Apr 21, 2026 · Senate
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. - Apr 21, 2026
Introduced in Senate